Tag: Stents
Long-Term Outcomes of PCI, CABG Compared for Multivessel CAD
Findings for median follow-up of 11.8 years reported from multicenter, randomized, controlled trial terminated early due to slow enrollment
No Increase in Long-Term Mortality Seen With Peripheral Drug-Coated Devices
DCDs noninferior to non-DCDs for survival among older adults who underwent femoropopliteal artery revascularization
Iliac Vein Stenting Appears Safe in Office-Based Lab Setting
7.36 percent of patients had minor complications, mainly insertion site hematomas; 0.41 percent had major complications
Cre8 EVO Stents Noninferior for PCI in Diabetes Patients With CAD
Cre8 EVO stents noninferior to Resolute Onyx stents for target-lesion failure composite outcome at one year
QFR-Guided Percutaneous Coronary Intervention Improves Outcomes
One-year clinical outcomes improved with quantitative flow ratio for lesion selection versus standard angiography guidance
FFR-Guided PCI Not Noninferior to CABG in Three-Vessel CAD
Findings not consistent with prespecified noninferiority of fractional flow reserve-guided percutaneous coronary intervention
Impact of Age Examined for Ticagrelor Monotherapy After PCI
Ticagrelor monotherapy reduces bleeding without increasing ischemic events among patients undergoing PCI
Ticagrelor, Prasugrel Compared in ACS Treated With PCI
Prespecified subgroup analysis of data from a randomized clinical trial suggest that a prasugrel-based strategy is preferable
Deaths Not Up With Paclitaxel-Coated Devices in PAD
Interim analysis shows no increased rate of all-cause mortality with paclitaxel-coated versus uncoated devices
